These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31823411)

  • 21. Rationale and design of the 'MITOCARE' Study: a phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction.
    MITOCARE Study Group
    Cardiology; 2012; 123(4):201-7. PubMed ID: 23202613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins.
    Butt N; Bache-Mathiesen LK; Nordrehaug JE; Tuseth V; Munk PS; Bonarjee V; Hall TS; Jensen SE; Halvorsen S; Firat H; Atar D; Larsen AI
    Cardiology; 2017; 138(2):122-132. PubMed ID: 28651249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria.
    Chen Q; Xu H; Xu A; Ross T; Bowler E; Hu Y; Lesnefsky EJ
    PLoS One; 2015; 10(3):e0118834. PubMed ID: 25756500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-type natriuretic peptide-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
    Sun Y; Zhang Y; Yan M; Wu Y; Zheng X
    Biol Pharm Bull; 2009 Sep; 32(9):1545-51. PubMed ID: 19721230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN; Zhou ZM; Chen P
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the MPTP in conditioning the heart - translatability and mechanism.
    Ong SB; Dongworth RK; Cabrera-Fuentes HA; Hausenloy DJ
    Br J Pharmacol; 2015 Apr; 172(8):2074-84. PubMed ID: 25393318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart.
    Javadov SA; Clarke S; Das M; Griffiths EJ; Lim KH; Halestrap AP
    J Physiol; 2003 Jun; 549(Pt 2):513-24. PubMed ID: 12692185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting cell death.
    Hausenloy DJ; Scorrano L
    Clin Pharmacol Ther; 2007 Oct; 82(4):370-3. PubMed ID: 17851576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection.
    Halestrap AP
    Biochem Soc Trans; 2010 Aug; 38(4):841-60. PubMed ID: 20658967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of cyclosporine in the treatment of myocardial reperfusion injury.
    Gill RS; Bigam DL; Cheung PY
    Shock; 2012 Apr; 37(4):341-7. PubMed ID: 22293599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasopressin attenuates ischemia-reperfusion injury via reduction of oxidative stress and inhibition of mitochondrial permeability transition pore opening in rat hearts.
    Nazari A; Sadr SS; Faghihi M; Azizi Y; Hosseini MJ; Mobarra N; Tavakoli A; Imani A
    Eur J Pharmacol; 2015 Aug; 760():96-102. PubMed ID: 25895639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the mitochondrial permeability transition: cardiac ischemia-reperfusion versus carcinogenesis.
    Javadov S; Hunter JC; Barreto-Torres G; Parodi-Rullan R
    Cell Physiol Biochem; 2011; 27(3-4):179-90. PubMed ID: 21471706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury.
    Sloan RC; Moukdar F; Frasier CR; Patel HD; Bostian PA; Lust RM; Brown DA
    J Mol Cell Cardiol; 2012 May; 52(5):1009-18. PubMed ID: 22406429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of mitochondrial permeability transition pores by cyclosporine A improves cytochrome C oxidase function and increases rate of ATP synthesis in failing cardiomyocytes.
    Sharov VG; Todor AV; Imai M; Sabbah HN
    Heart Fail Rev; 2005 Dec; 10(4):305-10. PubMed ID: 16583179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
    Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
    Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic protective effect of cyclosporin A and rotenone against hypoxia-reoxygenation in cardiomyocytes.
    Teixeira G; Abrial M; Portier K; Chiari P; Couture-Lepetit E; Tourneur Y; Ovize M; Gharib A
    J Mol Cell Cardiol; 2013 Mar; 56():55-62. PubMed ID: 23238221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.
    Hausenloy DJ; Ong SB; Yellon DM
    Basic Res Cardiol; 2009 Mar; 104(2):189-202. PubMed ID: 19242644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ru360, a specific mitochondrial calcium uptake inhibitor, improves cardiac post-ischaemic functional recovery in rats in vivo.
    García-Rivas Gde J; Carvajal K; Correa F; Zazueta C
    Br J Pharmacol; 2006 Dec; 149(7):829-37. PubMed ID: 17031386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
    Lu N; Sun Y; Zheng X
    Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
    Hausenloy D; Wynne A; Duchen M; Yellon D
    Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.